Valda Rodríguez, Luis2026-03-222026-03-221995https://andeanlibrary.org/handle/123456789/11465A randomized trial of amphotericin B (AB) alone and in combination with oral itraconazole (IZ) is carried out in two groups of 10 mucocutaneous leishmaniasis patients from Bolivia and Perú. AB+IZ combination is no better than AB monotherapy as far as efficacy and tolerability are concerned. No antagonism was detected.enLEISHMANIASIS MUCOCUTÁNEATRATAMIENTOANFOTERICINA BITRACONAZOLArticle